Jenna Davidner
Stock Analyst at Barclays
(0.55)
# 3,906
Out of 4,352 analysts
20
Total ratings
7.1%
Success rate
-11.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $18 | $9.59 | +87.70% | 3 | May 15, 2026 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $100 | $59.40 | +68.35% | 5 | May 15, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $25 | $23.22 | +7.67% | 4 | May 14, 2026 | |
| XERS Xeris Biopharma Holdings | Rated: Buy | $9 | $6.16 | +46.10% | 3 | May 13, 2026 | |
| COLL Collegium Pharmaceutical | Rated: Buy | $56 | $33.61 | +66.62% | 5 | May 12, 2026 |
Phathom Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $9.59
Upside: +87.70%
Tarsus Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $100
Current: $59.40
Upside: +68.35%
Pacira BioSciences
May 14, 2026
Maintained: Hold
Price Target: $25
Current: $23.22
Upside: +7.67%
Xeris Biopharma Holdings
May 13, 2026
Rated: Buy
Price Target: $9
Current: $6.16
Upside: +46.10%
Collegium Pharmaceutical
May 12, 2026
Rated: Buy
Price Target: $56
Current: $33.61
Upside: +66.62%